Bristol to Pay $13.1 Billion for Heart-Drug Maker MyoKardia
Cancer-drug powerhouse Bristol Myers Squibb said it will buy biotech MyoKardia in a $13.1 billion all-cash deal aimed at expanding its...
Full Article
Bristol to Pay $13.1 Billion for Heart-Drug Maker MyoKardia
Upworthy
0 shares
1 views
You might like
Related news coverage
Regeneron, MyoKardia rise; DraftKings, AMC fall
SeattlePI.com
NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:
HMS Holdings Corp., up $3.02 to..
-
US stocks rebound as investors bet on renewed hopes for stimulus deal
Proactive Investors
-
Bristol Myers Squibb Begins a $13.1 Billion Purchase of MyoKardia
Motley Fool
-
US stocks higher and FTSE 100 closes up as sentiment is boosted on US stimulus package hopes
Proactive Investors
-
US benchmarks race out of the blocks Monday on reports of President Trump's health and stimulus package hopes
Proactive Investors